Latest NewsAssisted Reproductive Technology Market worth US$6.02 Billion by 2030 PatApril 25, 2025 Increased levels of infertility caused by stress, lifestyle changes, and medical conditions are among the key drivers affecting the assisted reproductive technology (ART) market. The sector has expanded due to technological advancements such as preimplantation genetic testing (PGT), embryo freezing, and enhanced in-vitro fertilization (IVF) techniques that have significantly improved success rates. Industry growth is prevented by ethical and regulatory issues, including legal bans, expensive processes, and the ethical debate over the handling of embryos and surrogacy. Government backing from the state, a change in social perception, and rising public awareness all drive market growth. Improved healthcare infrastructure and greater disposable incomes in the developing world can spur developments in ART therapy. ARTHealthcareInfertilityReproductive rights
